Close correlation of the cardioprotective effect of fk409, a spontaneous no releaser, with an increase in plasma cyclic gmp level.FK409 ((+/-)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexeneamide) , which has been reported by us to be a new spontaneous nitric oxide (NO) releaser, prevented myocardial infarction following occlusion and reperfusion in rat coronary artery and increased plasma cyclic GMP level in rats, dose-dependently and significantly...
Antiplatelet activities of fk409, a new spontaneous no releaser.... The aim of this study was to compare antiplatelet activities of FK409, a new NO releaser, with those of isosorbide dinitrate (ISDN) in vivo and in vitro....
Photomanipulationof vasodilation with a blue-light-controllablenitric oxide releaserSpatiotemporallycontrollable nitric oxide (NO)-releasers allowus to analyze the physiological effects of NO, a gaseous mediatorthat modulates many biological signaling networks, and are also candidatechemotherapeutic agents....
The research and analysis of one new deep-sea releaser... Deep-sea releaser is very key element in the research of deep-sea scientific and has broad applications, the most typical releaser is the acoustic releaser....
